Rice Hall James & Associates, LLC Maxcyte, Inc. Transaction History
Rice Hall James & Associates, LLC
- $1.53 Billion
- Q1 2025
A detailed history of Rice Hall James & Associates, LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 454,365 shares of MXCT stock, worth $1.29 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
454,365
Previous 263,833
72.22%
Holding current value
$1.29 Million
Previous $1.1 Million
13.04%
% of portfolio
0.08%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding MXCT
# of Institutions
124Shares Held
70.7MCall Options Held
8.7KPut Options Held
6K-
Cadian Capital Management, LP New York, NY9.34MShares$26.5 Million2.26% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$23.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.43MShares$15.4 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$14.3 Million18.06% of portfolio
-
Morgan Stanley New York, NY4.41MShares$12.5 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $289M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...